joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017.
Results of evaluation of MicroPort Orthopedics’ Medial Pivot Knee demonstrated 95.0% satisfaction and 98.8% survivorship at 17 years, with patients reporting high stability and comfort during regular activity.